唐氏综合征相关烟雾病综合征的延迟识别与卒中为主表现
多中心回顾性队列研究比较唐氏综合征相关烟雾病综合征(DS-MMS)与无唐氏综合征的烟雾病(MMS)患儿,发现DS-MMS以卒中为首发症状的比例更高(71.4% vs 20.7%),诊断延迟更长,后循环受累更常见,诊断前收缩压百分位进行性升高,1年残疾和痉挛更重;提示需针对性早期检测并降低血管影像门槛。
要点
- DS-MMS患儿以卒中为首发症状的风险显著高于无DS的MMS患儿(调整OR 14.50)。
- DS-MMS从症状出现到就诊及从就诊到确诊的延迟均更长(均P<0.001)。
- 诊断前收缩压百分位进行性升高,可能作为早期生理信号。
核心结论
- DS-MMS是一种高风险脑血管表型,特征为识别延迟和就诊时卒中可能性显著增加。
- 诊断前血压百分位升高可能作为早期生理信号,支持针对性早期检测策略。
- 对有症状患者应降低血管影像检查门槛。
研究设计与样本
- 多中心回顾性队列研究,比较DS-MMS与无DS的MMS患儿。
- 共识别271例患者,198例(73.1%)符合纳入标准组成分析队列(DS-MMS 77例,MMS 121例)。
- DS-MMS平均年龄9.5±5.2岁(女性50.6%),MMS平均年龄7.4±3.0岁(女性54.5%)。
- 主要结局为卒中作为主要就诊症状,次要结局包括诊断延迟、血管造影特征、诊断前收缩压百分位和1年神经结局。
- 多变量模型调整人口学和就医可及性相关协变量。
主要发现
- DS-MMS就诊时卒中更常见(71.4% vs 20.7%;绝对差50.8%),调整OR 14.50(95%CI 6.65-31.60;P<0.001)。
- DS-MMS从症状出现到就诊及从就诊到诊断确认的延迟均更长(均P<0.001)。
- DS-MMS后循环受累更常见(调整OR 2.18 [95%CI 1.09-4.37];P=0.03),血管造影严重程度两组相似。
- 诊断前DS-MMS收缩压百分位进行性升高,超过MMS队列6个月(P<0.001)。
- 1年时DS-MMS残疾更重(调整OR 2.58 [95%CI 1.45-4.57];P<0.001)和痉挛更多(调整OR 6.33 [95%CI 3.12-12.83];P<0.001)。
临床怎么用
- 对唐氏综合征患儿应提高烟雾病综合征警惕,降低血管影像检查门槛。
- 监测收缩压百分位变化可能有助于早期识别DS-MMS。
- 对有神经系统症状的DS患儿应加快诊断流程以减少延迟。
局限性
- 回顾性队列设计可能存在选择和信息偏倚。
- 原文未报告多中心具体中心数量及随访完整性细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Children with Down syndrome (DS) are at high risk for moyamoya syndrome (MMS) and ischemic stroke, yet early detection strategies remain poorly defined despite the condition being surgically treatable. METHODS: We conducted a multicenter retrospective cohort study comparing children with Down syndrome-associated moyamoya syndrome (DS-MMS) and MMS without DS (MMS). The primary outcome was stroke as the primary presenting symptom. Secondary outcomes included diagnostic delays, angiographic features, prediagnostic systolic blood pressure percentiles, and 1-year neurological outcomes. Multivariable models adjusted for demographic and access-related covariates. RESULTS: In total, 271 patients were identified; 198 (73.1%) met inclusion criteria and comprised the analytic cohort. Among 198 patients (77 DS-MMS; 121 MMS), DS-MMS mean age was 9.5±5.2 years (50.6% female patients), and MMS mean age was 7.4±3.0 years (54.5% female patients). Stroke at presentation was more common in DS-MMS (71.4% versus 20.7%; absolute difference, 50.8%), corresponding to an adjusted odds ratio of 14.50 ([95% CI, 6.65-31.60]; P<0.001). Children with DS-MMS experienced longer delays from symptom onset to presentation and from presentation to diagnostic confirmation (both P<0.001). Posterior circulation involvement was more frequent in DS-MMS (adjusted odds ratio, 2.18 [95% CI, 1.09-4.37]; P=0.03), whereas angiographic severity was similar between groups. In the prediagnostic period, DS-MMS demonstrated a progressive rise in systolic blood pressure percentiles, exceeding the MMS cohort by 6 months (P<0.001). At 1 year, DS-MMS was associated with greater disability (adjusted odds ratio, 2.58 [95% CI, 1.45-4.57]; P<0.001) and spasticity (adjusted odds ratio, 6.33 [95% CI, 3.12-12.83]; P<0.001). CONCLUSIONS: DS-MMS represents a high-risk cerebrovascular phenotype characterized by delayed recognition and a markedly increased likelihood of stroke at presentation. Rising blood pressure percentiles preceding diagnosis may serve as an early physiological signal. These findings support targeted early detection strategies and a lower threshold for vascular imaging in symptomatic patients.
引用
- Santoro JD, Silverman M, Wang AC, et al. Delayed Recognition and Stroke-Predominant Presentation in Down Syndrome-Associated Moyamoya Syndrome. Stroke. 2026. PMID: 42495733. doi:10.1161/STROKEAHA.126.056969
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。